The Antidepressant Web: Contents Page

1PREAMBLE
1.1 Introduction 1.11 Re: PIRC/Social Audit
1.2 Web overview 1.21 Publications list                   1.22 How to order reports
1.3 Abstract 1.35 Download this report       
2   BENEFITS?
2.1 Do antidepressants work?
2.2 When antidepressants were first used
2.3 Treatment of depression: the first 30 years
2.4 Treating depression: the 1990s
2.5 The definition of depression
2.6 Diagnosis - Anxiety or depression?
2.7 Standards for testing the efficacy of SSRIs
2.8 Blindness, placebo response in trials
2.9 Clinical advantages claimed for SSRIs
2.10 Prozac, suicide and aggression
2.11 The popularity of Prozac and other SSRIs
2.12 Defeating Depression
2.13 Treatment guidelines, prescribing modes
3RISKS?
3.1 Dependence as an iatrogenic disease
3.2 Withdrawal from original antidepressants
3.3 Withdrawal problems with SSRIs
3.4 Some SSRI users’ views
3.5 Where the goalposts of dependence used to be
3.6 Warnings and prescribing advice
3.7 Benefits of long-term use
3.8 Risks of long-term use
3.9 What passes for progress

 

4.DEVELOPMENTS SINCE PUBLICATION UPDATES
4.1 Text references August 2003
4.2 Additional published evidence and reviews Dec 2001
     PUBLISHED REPORTS ON SSRI WITHDRAWAL August 2003
DO ANTIDEPRESSANTS CAUSE DEPENDENCE? April 1999
DIRECT TO CONSUMER ADVERTISING Dec 2001
COSTLY BENEFITS AND THE CONSPIRACY OF GOODWILL Sept 2000
Information Management, Conflicts of Interest and the safety of SSRIs August 2003
Matters arising:    4.3 - Government agencies
Medicines Control Agency/Committee on Safety of Medicines August 2003
Department of Health August 2003
Chief Medical Officer of Health, Prime Minister Late 1997
Parliamentary Select Committee on Health Oct 1998
European Medicines Control Agency           Dec 2000
Committee on Standards in Public Life June 1998
Audit Commission July 1998
Parliamentary Commissioner for Administration (Ombudsman) Dec 2000
CORRESPONDENCE BETWEEN DR DAVID HEALY AND THE MCA July 2003
Re: Freedom of Information -
Chancellor of the Duchy of Lancaster, Cabinet Office Promises 1996-1998
The Home Office Realities 1999
Freedom of Information?  Forget it Crunch 2000
Freedom of Information Act Future from 2002
Matters arising:    4.4 - Medical organisations
Royal College of Psychiatrists
Royal College of General Practitioners
World Health Organisation Dec 1999
Matters arising:    4.5 - Pharmaceutical companies

`

Manufacturers of SSRI antidepressants
SmithKline Beecham - UK (re: Seroxat/Paxil - 1997) Oct 2002
SmithKline Beecham - USA (ditto - Autumn 2000) Oct 2000
IFPMA - International Federation of Pharmaceutical Manufacturers' Associations Sept 2001
Prescription Medicines Code of Practice Authority March 2003
Eli Lilly (re: sponsorship of fluoxetine trials) Jan 1999
5DISCUSSION 1998 to date
5.1 Editorial notes and What's New                   November 2003
5.2 Overview comments from readers
5.3 Is this a true and fair view? No?
Maybe?
Yes?
6. MEDICINES OUT OF CONTROL?
     Antidepressants and the Conspiracy of Goodwill
March 2004